Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02422407 · ClinicalTrials.gov registry record

A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome

A clinical trial of Healthy and Sjögren's Syndrome, sponsored by Biogen.

Completed
Registry status
100
Enrollment target
4
Study locations

NCT02422407 is a study of Healthy and Sjögren's Syndrome that has completed, run by Biogen. The registered enrollment target is 100 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02422407, a study of Healthy and Sjögren's Syndrome, has completed, sponsored by Biogen.

COMPLETED
Registry status
100 participants
Enrollment target
4
Study locations

Study Summary

The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.

Interventions

  • PROCEDURE Biopsy

Study Locations (4)

Connecticut

  • Research Site - Hartford

Massachusetts

  • Research Site - Boston

Pennsylvania

  • Research Site - Philadelphia

Texas

  • Research Site - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-03-26
Est. Completion 2017-08-22

Sponsor

Biogen

334 total trials

What the Registry Record Tells You About NCT02422407

The ClinicalTrials.gov registry entry for NCT02422407 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Biopsy is the first listed.

NCT02422407 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Connecticut, Massachusetts, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02422407 about?

NCT02422407 is a clinical study titled "A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome". The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.

What is the current status of trial NCT02422407?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-03-26. Estimated completion is 2017-08-22.

What conditions does trial NCT02422407 study?

This clinical trial studies the following conditions: Healthy, Sjögren's Syndrome, Sicca Syndrome.

What interventions are being tested in trial NCT02422407?

The interventions under investigation include: Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02422407?

This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02422407 being conducted?

This trial has 4 study locations across Connecticut, Massachusetts, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.